Two and a half years into the COVID-19 pandemic, we have gained many insights into the
human antibody response to the causative SARS-CoV-2 virus. In this Review, we …

Abstract Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Despite pulmonary impairments being the most …

Post‑viral syndrome is a well‑known medical condition characterized by different levels of
physical, cogni‑tive, and emotional impairment that may persist with fluctuating severity after …

With the advent of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
pandemic, several vaccines have been developed to mitigate its spread and prevent …

Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), the cause of COVID-19
disease, has the potential to elicit autoimmunity because mimicry of human molecular …

As the COVID-19 pandemic continues into its third year, emerging data indicates increased
risks associated with SARS-CoV-2 infection during pregnancy, including pre-eclampsia …

Background: This study monitored total anti-SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) RBD (receptor-binding domain) antibodies levels in a large …

Since previous evidence has demonstrated that red blood cell distribution width (RDW) may
be a useful prognostic parameter in many critical illnesses and infectious diseases, we …

Background Neurological symptoms are frequent among patients with COVID-19. Little is
known regarding the repercussions of neurological symptoms for patients and how these …

The novel beta coronavirus (SARS-CoV-2, designated as COVID-19) that is responsible for
severe acute respiratory syndrome has devastated the global economy and health care …